CLOV vs SPRO
Clover Health Investments Corp (CLOV) versus Spero Therapeutics Inc (SPRO) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported SPRO revenue for 2024-12-31 was $48.0M. Net income was -$68.6M. Revenue was down 53.8% from 2023-12-31 to 2024-12-31. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
CLOV currently screens at market cap $1.55B. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Not investment advice. Open the CLOV and SPRO stock pages for the full models.
Not investment advice.